A large, multi-institution study led by a Brown University physician-scientist could have important implications for the development of new classes of cancer therapeutics.

A newly identified cancer pathway may finally reveal how to stop pancreatic tumors before they spread. A Cornell-led research effort has uncovered how a highly aggressive type of pancreatic cancer is ...

Datopotamab deruxtecan received FDA approval for HR+/HER2– breast cancer, improving progression-free survival and overall ...

A study by the Mildred Scheel Early Career Center group led by Dr. Mohamed Elgendy at the TUD Faculty of Medicine provides fundamental insights into cancer biology.

Gastric (stomach) cancer remains one of the most common and deadly cancers in East Asia, including Korea. Yet despite its ...

The biotech will now take atebimetinib to mid- and late-stage trials in NSCLC and pancreatic cancer, respectively.

As mentioned above, 2025 has seen all sorts of promising advancements when it comes to breast cancer research. Flow Space ...

The blood-based test by Astrin Biosciences shows high sensitivity and specificity across cancer stages and subtypes, ...

A combination of two supplements — resveratrol and copper — reduced the aggressiveness of tumors in glioblastoma, a type of ...

SEATTLE — Cancer fighters of all ages are gathering to strut their stuff for an organization that's been supporting patients and families for decades. The fashion show "Surviving with Style" is set ...